Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5173305
Max Phase: Preclinical
Molecular Formula: C35H44ClN3O6
Molecular Weight: 638.21
Associated Items:
ID: ALA5173305
Max Phase: Preclinical
Molecular Formula: C35H44ClN3O6
Molecular Weight: 638.21
Associated Items:
Canonical SMILES: CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)OCCCn4cc([N+](=O)[O-])nc4Cl)CC[C@]3(C)CC[C@]12C
Standard InChI: InChI=1S/C35H44ClN3O6/c1-21-22-8-9-25-33(4,23(22)18-24(40)28(21)41)13-15-35(6)26-19-32(3,11-10-31(26,2)12-14-34(25,35)5)29(42)45-17-7-16-38-20-27(39(43)44)37-30(38)36/h8-9,18,20,26,41H,7,10-17,19H2,1-6H3/t26-,31-,32-,33+,34-,35+/m1/s1
Standard InChI Key: QHBZROOTFSFIMF-JVIXZCSZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 638.21 | Molecular Weight (Monoisotopic): 637.2919 | AlogP: 8.00 | #Rotatable Bonds: 6 |
Polar Surface Area: 124.56 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.75 | CX Basic pKa: | CX LogP: 6.89 | CX LogD: 6.89 |
Aromatic Rings: 1 | Heavy Atoms: 45 | QED Weighted: 0.14 | Np Likeness Score: 1.78 |
1. Li N, Xu M, Zhang L, Lei Z, Chen C, Zhang T, Chen L, Sun J.. (2022) Discovery of Novel Celastrol-Imidazole Derivatives with Anticancer Activity In Vitro and In Vivo., 65 (6.0): [PMID:35238566] [10.1021/acs.jmedchem.1c01293] |
Source(1):